Dupont Capital Management Corp Bluebird Bio, Inc. Transaction History

Dupont Capital Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$27.5 - $37.92 $157,905 - $217,736	-5,742 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$34.44 - $43.75 $41,672 - $52,937	-1,210 Reduced 17.41%	5,742 $310,000
Q2 2020 Jul 24, 2020	BUY	$27.12 - $45.97 $188,538 - $319,583	6,952 New	6,952 $424,000
Q4 2018 Feb 01, 2019	SELL	$59.1 - $93.26 $146,981 - $231,937	-2,487 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$88.86 - $117.49 $220,994 - $292,197	2,487 New	2,487 $363,000
Q2 2018 Jul 30, 2018	SELL	$99.64 - $127.59 $758,758 - $971,597	-7,615 Closed	0 $0
Q1 2018 May 02, 2018	SELL	$105.8 - $150.94 $288,728 - $411,915	-2,729 Reduced 26.38%	7,615 $1.3 Million
Q4 2017 Jan 31, 2018	BUY	$81.25 - $130.7 $183,787 - $295,643	2,262 Added 27.99%	10,344 $1.84 Million
Q3 2017 Oct 31, 2017	BUY	$57.74 - $91.42 $466,654 - $738,856	8,082	8,082 $1.11 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.